InvestorsHub Logo
Post# of 250027
Next 10
Followers 788
Posts 118648
Boards Moderated 15
Alias Born 09/05/2002

Re: DewDiligence post# 237013

Thursday, 06/10/2021 11:50:32 AM

Thursday, June 10, 2021 11:50:32 AM

Post# of 250027
BMY—Breyanzi shows phase-3 statsig-superior EFS compared to SoC (high-dose chemo followed by stem-cell transplant) in second-line, large B-cell lymphoma:

Bryanzi’s existing label includes only the third-line setting (#msg-161552697).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.